Home / Varenicline / Czechia
CZ ATC N07BA03 · updated 2 Nov 2026
Varenicline shortage in Czechia
Is there a Varenicline shortage in Czechia?
Yes. As of 2 Nov 2026, 3 Varenicline products are reported short in Czechia, the first since 13 Jul 2026. The company estimate for the return is 5 Nov 2026 (latest 30 Nov 2026). Main reason: commercial decision or withdrawal.
Also short in Canada, Ireland, Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | VARENICLINE GLENMARK 0,5MG 0,5MG TBL FLM 11 | Glenmark Pharmaceuticals s.r.o., Praha | 13 Jul 2026 | 5 Nov 2026 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | VARENICLINE GLENMARK 1MG 1MG TBL FLM 56 | Glenmark Pharmaceuticals s.r.o., Praha | 13 Jul 2026 | 30 Nov 2026 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | VARENICLINE GLENMARK 1MG 1MG TBL FLM 28 | Glenmark Pharmaceuticals s.r.o., Praha | 27 Jul 2026 | 30 Nov 2026 | Commercial decision or withdrawal Obchodní/marketingové důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.